- rev $2.01
- book value $0.76
- EPS $0.10
Thursday, December 30, 2021
Monday, November 29, 2021
Anyone out there who owns shares please email me email@example.com. I am trying to figure out how many shares I know of that will not accept. I know we only have until Dec 3 so I am late with this post (family/Firebird getting in the way).
You can find the official offer and latest annual report here. Table of numbers is below
Thursday, October 7, 2021
I like to buy stocks at the bottom, when the narrative has broken down and masses have left. This is when it gets interesting. Stock_price = company_value + public_perception so how can you buy on the cheap unless the sky is filled with doom and gloom.
I first bought ECIA around $0.30 and wrote up the stock a couple years ago at $0.39. It had dropped to support, near the all time low. With an exciting medical business and tons of potential I bought with dollar signs in my eyes.
What I do is buy tiny, low, sleepy stocks with potential then wait and watch. Potential comes from both business and stock. I like a business with room to grow. The stock should be low with capital structure tight, and bonus points for a theme that can be meme'd to the moon.
After the buy starts a years long process of optimistically following along. I can see the rise in my mind. If things don't go my way I wait longer and as the situation warrants I buy more. This is the story of puzzle pieces falling into place.
Tuesday, September 21, 2021
Monday, August 30, 2021
Saturday, July 31, 2021
Now that the SEC followed through with their rule 15c2-11 change blocking quotes from non-reporting companies, the brokerages are all backing away. I don't know if the SEC realized this would happen but it seems like every online brokerage company's response is to just take their ball and go home.
In recent weeks we've seen announcements from Schwab, TDAmeritrade, and others saying they will not allow clients to purchase non-reporting stocks after August 2021. Unfortunately I don't know of a single online brokerage that will let you buy dark stocks after the rule change goes into effect in Sept 2021.
I was a guest on The Investor's Roundtable the other day to discuss this topic. You can hear the audio here and watch video here. Give it a listen to hear my own opinion as well as some others I really respect. I have to say it was a real trip to be on a panel with my hero Dave Waters of OTC Adventures / Alluvial Capital.
Sunday, July 18, 2021
A couple weeks ago the company put out a tender offer to buy out all sharesholders at $10 (oddballstocks wrote up a nice summary here).
Saturday, May 29, 2021
There are many different situations in my portfolio and they all have one theme in common: potential. I'm here for the potential to change my life.
Pieris Pharmaceuticals (PIRS) is a "clinical-stage biotechnology company that discovers and develops Anticalin-based drugs to target validated disease pathways in unique and transformative ways". Agreements with a number of huge companies give PIRS total potential milestone payments of over 30x the current market cap, plus royalties! Sound interesting?
Sunday, April 18, 2021
Thursday, April 8, 2021
I did most of my PGNT buying a year ago and with the stock up over 200% I'm still adding. This one may keep going so let's take a look.
It's been a while since we played our favorite game, Price That Stock! Here we go. No looking at the stock price before playing. Humor me
Thursday, March 11, 2021
I recorded a fun podcast yesterday with Gary Ribe and Eric Furey, In the Market Trenches. I had a great time talking about my approach, how I do things, and why I do things. We did a little deep dive into two strange, yet somehow normal in the dark space, stock stories: EKCS and VCON.
Monday, February 8, 2021
For all my negativity and rants towards companies de-registering from the SEC, sometimes it does help operations. It definitely saves them money and enables them to spend more time on the business.
The real risk is communication. If they cut the world off the stock can drop to nothing but as long as they keep talking good things can happen.
Dynasil (DYSL) de-registered from the SEC in the fall of 2019 with the hope of saving $900k per year. They filed their last 10k in Dec 2019 and told shareholders to only expect an annual report moving forward. A week ago they put out the report and the numbers back up their motivation for de-registering.